成人H3 K27变异型弥漫性中线胶质瘤的临床、分子及影像特征与结局的多中心综合分析
该多中心回顾性研究纳入111例成人H3 K27变异型弥漫性中线胶质瘤患者,分析其临床、分子、影像及生存特征,并与365例患儿比较。成人患者男性比例更高、组织学4级比例更低、肿瘤位置不同,总生存期长于患儿(30.3 vs 12.0个月)。作者认为在可行时应积极手术以改善生存。
要点
- 成人H3 K27变异型弥漫性中线胶质瘤好发于丘脑(41.5%)和脊髓(27.0%),患儿则多见于脑桥(64.9%)。
- 成人总生存期30.3个月,长于患儿的12.0个月(p < 0.001)。
- 诊断年龄较大、组织学分级较低、非强化肿瘤全切除为独立有利预后因素。
核心结论
- 成人H3 K27变异型弥漫性中线胶质瘤的临床、组织学及影像特征与患儿不同,预后显著更好。
- 作者认为在认为可行时应积极手术以求更好的生存结局。
研究设计与样本
- 回顾性病历与影像复习,纳入两家三级机构111例成人H3 K27变异型弥漫性中线胶质瘤患者。
- 与既往多中心Meta分析数据集中的365例患儿进行比较。
- 采用Cox分析确定成人总生存期的预测因素。
主要发现
- 成人中位年龄40岁(范围18-75岁),男性64例、女性47例。
- 成人男性比例57.7% vs 患儿45.3%(p = 0.023),组织学4级比例41.4% vs 74.0%(p < 0.001),肿瘤位置分布不同(p < 0.001)。
- 成人常见丘脑(41.5%)和脊髓(27.0%),患儿以脑桥为主(64.9%)。
- 成人总生存期30.3个月 vs 患儿12.0个月(p < 0.001,log-rank检验)。
- 诊断年龄较大(HR 0.96,p = 0.001)、组织学分级较低(HR 0.25,p = 0.003)、非强化肿瘤全切除(HR 0.15,p = 0.003)为独立有利预后因素。
临床怎么用
- 作者认为在认为可行时应积极手术以求更好的生存结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective was to comprehensively investigate the clinical, molecular, and imaging characteristics and outcomes of H3 K27-altered diffuse midline glioma (DMG) in adults. METHODS: Retrospective chart and imaging reviews were performed in 111 adult patients with H3 K27-altered DMG from two tertiary institutions. Clinical, molecular, imaging, and survival characteristics were analyzed. Characteristics were compared between adult and 365 pediatric patients from a previous multicenter meta-analysis dataset. Cox analyses were performed to determine predictors of overall survival (OS) in adult patients. RESULTS: The median (range) age of adult patients was 40 (18-75) years, and 64 males and 47 females were included. Adults had a higher male proportion (57.7% vs 45.3%, p = 0.023), lower proportion of histological grade 4 (41.4% vs 74.0%, p < 0.001), and different tumor locations (p < 0.001) compared with pediatric patients; adults commonly showed a thalamus location (41.5%) followed by the spinal cord (27.0%), whereas pediatric patients predominantly showed a pons location (64.9%). The OS of adults was longer than that of pediatric patients (30.3 vs 12.0 months, p < 0.001, log-rank test). Older age at diagnosis (HR 0.96, p = 0.001), histologically lower grade (HR 0.25, p = 0.003), and gross-total resection of nonenhancing tumor (HR 0.15, p = 0.003) were independent favorable prognostic factors. CONCLUSIONS: Adult patients with H3 K27-altered DMG showed distinct clinical, histological, and imaging characteristics compared to pediatric counterparts, with a significantly better prognosis. The authors' results suggest that aggressive surgery should be pursued when deemed feasible for better survival outcomes.
引用
- Sim Y, McClelland AC, Choi K, et al. A comprehensive multicenter analysis of clinical, molecular, and imaging characteristics and outcomes of H3 K27-altered diffuse midline glioma in adults. J Neurosurg. 2025. PMID: 39793011. doi:10.3171/2024.8.JNS241180
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。